tiprankstipranks
Advertisement
Advertisement

Hemab Therapeutics 16.75M share IPO priced at $18.00

The deal size was increased to 16.75M shares from 15.0M and priced at top end of $16.00-$18.00 target range. Goldman Sachs, Jefferies and Evercore ISI are acting as joint book running managers for the offering.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1